Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 08 Jul 2024 for Fulcrum Therapeutics, Inc., €454k. Read the official filing
Filing timeline
BuySaleAlex Sapir
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Alex Sapir: trading record in brief
Filings by Alex Sapir span 2 companies, the busiest being Fulcrum Therapeutics, Inc. and PhaseBio Pharmaceuticals Inc. Over a trading history stretching from 19 May 2023 to 3 July 2024, the count stands at 3 filings.
On the market, this insider has only ever bought: 1 purchase, €454k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 2 option exercises. Since January 2024: 1 purchase and no sales on the market.
The record was last updated on 8 July 2024 with an option exercise (€454k) in Fulcrum Therapeutics, Inc. The last purchase on record was published on 5 March 2024, which is 957 days ago. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Alex Sapir
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
150,000 shares@ US$3.2750.0% of flowCommon StockSEC:0000950170-24-081949:0
43,360 shares@ US$11.347550.0% of flowCommon StockSEC:0000950170-24-025933:0
Canonical exit: 2 Jun 2024 (T+90)
3,750 sharesCommon StockSEC:0001169245-23-000029:0
3 of 3 declarations
